Engineered Proline Hydroxylases for High-Purity Hydroxylated Compounds
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for synthesizing hydroxylated proline and proline analogs face challenges such as limited availability of raw materials, complex chemical synthesis steps, and the need for additional purification due to multiple hydroxylated products, as well as limitations in scalability and purity using whole cell systems.
Innovation Solution
Engineering proline hydroxylase biocatalysts with improved properties, including activity, regioselectivity, and substrate tolerance, to convert (S)-pipecolic acid into (2S,5S)-5-hydroxypipecolic acid using alpha-ketoglutarate as a co-substrate, conducted in the presence of oxygen and iron.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemical synthesis methods are used to produce hydroxylated proline, then production capacity can be increased, but the process becomes complex and requires additional purification steps due to multiple hydroxylated products
Solution Approach 1:
The patent changes the fundamental parameter of the synthesis method from chemical catalysis to enzymatic catalysis. The enzyme proline hydroxylase provides high regioselectivity and stereoselectivity, producing only the desired hydroxylated proline isomer without forming multiple products that require purification. This enzymatic approach simplifies the process while maintaining high production capacity.
Solution Approach 2:
The patent employs a reusable enzyme catalyst that can be recovered and reused multiple times. The enzyme system avoids the need for complex purification processes and multiple synthesis steps, providing an economical and efficient production method that maintains high productivity without increasing process complexity.
2Productivity
If whole cell systems are used for hydroxylation, then scalability is improved, but substrate permeability limitations and competitive inhibition reduce efficiency
Solution Approach 1:
The patent extracts the hydroxylase enzyme activity from the whole cell system and implements it as a purified enzyme or cell-free system. This allows direct application to substrates without being constrained by cell membrane permeability issues. The enzyme can process a wide range of substrates including proline and pipecolic acid derivatives with high efficiency, overcoming the substrate permeability limitations of whole cell systems.
Solution Approach 2:
The patent changes the system from intact whole cells to purified enzyme or cell-free extracts. This parameter change eliminates the barrier of substrate permeability while maintaining scalability. The enzyme system can be optimized for specific substrates and can operate with high substrate concentrations without the competitive inhibition that occurs in whole cell systems.
3Manufacturing precision
If natural sources are used for hydroxyproline, then purity is achieved, but availability is limited and certain diastereomers are lacking
Solution Approach 1:
The patent changes from natural extraction to enzymatic synthesis. The proline hydroxylase enzyme provides precise control over the hydroxylation process, producing high purity products with specific diastereomers (cis-4-hydroxyproline and trans-4-hydroxyproline). This synthetic approach is not limited by the availability of natural sources and can produce any required diastereomer by controlling reaction conditions.
Solution Approach 2:
The patent uses a stable, reusable enzyme catalyst that can be produced through recombinant DNA technology. This eliminates dependence on limited natural sources and provides a consistent, reliable supply of high purity hydroxylated proline and pipecolic acid derivatives. The enzyme system can be scaled up for industrial production without being constrained by natural material availability.
4Manufacturing precision
If proline hydroxylase is used for hydroxylation, then regioselectivity is improved, but enzyme stability under reaction conditions is reduced
Solution Approach 1:
The patent employs engineered enzyme variants or immobilized enzymes that enhance stability while maintaining high regioselectivity. The enzyme can be modified through protein engineering to improve its stability under reaction conditions (temperature, pH, substrate concentration) while preserving its ability to produce specific hydroxylated products with high diastereomeric excess.
Solution Approach 2:
The patent optimizes reaction parameters (temperature, pH, co-substrate concentration) to match the enzyme's optimal activity range, thereby enhancing stability. The enzyme proline hydroxylase requires specific conditions including alpha-ketoglutarate and oxygen as co-substrates, and the reaction is conducted under controlled pH and temperature to maintain enzyme stability while achieving high regioselectivity and product purity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered proline hydroxylases achieve high diastereomeric excess and improved stability, enabling scalable and efficient production of hydroxylated compounds with enhanced purity and versatility in substrate use.
Implementation Method 1
Engineering proline hydroxylase biocatalysts with improved properties, including activity, regioselectivity, and substrate tolerance, to convert (S)-pipecolic acid into (2S,5S)-5-hydroxypipecolic acid
Implementation Method 2
The engineered proline hydroxylases achieve high diastereomeric excess and improved stability, enabling scalable and efficient production of hydroxylated compounds
Implementation Method 3
conducted in the presence of oxygen and iron
Data Source
AI summary
The present invention provides engineered proline hydroxylase polypeptides for the production of hydroxylated compounds, polynucleotides encoding the engineered proline hydroxylases, host cells capable of expressing the engineered proline hydroxylases, and methods of using the engineered proline hydroxylases to prepare compounds useful in the production of active pharmaceutical agents.